江蘇荃信生物醫藥股份有限公司（股票名称：荃信生物-B，股票代码：02509）于2026年4月9日披露截至2026年3月31日的月度证券变动报告。报告期为2026年3月1日至3月31日。
根据公告显示，公司注册股份总数在本月末维持为227,071,600股，面值为每股人民币1元。普通H股于期末的已发行股数保持在224,567,600股，库存股数维持2,504,000股，合计227,071,600股，与上月末持平，未发生新增发行、回购或注销。
公告同时确认，当月未出现任何股份期权、权证或可转债的授出、行使或失效，也未有其他股份变动安排。公司指出，本月末已满足最低公眾持股量要求。
截至报告期末，公司股本结构整体维持稳定。公司声明已遵守香港交易及结算所有限公司《上市规则》以及相关法规要求。该公告由董事会秘书和联席公司秘书胡衍保签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.